Á lódáil...
Lenalidomide, idelalisib, and rituximab are unacceptably toxic in patients with relapsed/refractory indolent lymphoma
Na minha lista:
Foilsithe in: | Blood |
---|---|
Main Authors: | , , , , , |
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
American Society of Hematology
2015
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5161005/ https://ncbi.nlm.nih.gov/pubmed/25999447 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-03-633156 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|